
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients
CNN
Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
More Related News
